PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
24-Oct-2023 ImmunOs Therapeutics Presents Overview of Phase 1a/b Trial of Lead Compound IOS-1002 ImmunOs Therapeutics
23-Oct-2023 KITE’S CAR T-CELL THERAPY YESCARTA® (AXICABTAGENE CILOLEUCEL) COMPARED WITH BISPECIFICS IN R/R DLBCL IN TWO ANALYSES AT ESMO 2023 Kite Pharma
18-Oct-2023 Biomapas Achieves Notable Recognition with Nomination for HSJ Patient Safety Awards 2023 Biomapas
17-Oct-2023 Scientists reverse drug resistance in prostate cancer by targeting 'hijacked' white blood cells The Institute of Cancer Research
17-Oct-2023 New publication shows XF-73 drug potent against 2,527 Staphylococcus isolates Largest study of its kind to date demonstrates effectiveness of XF-73 against all tested antibiotic resistant strains Destiny Pharma
17-Oct-2023 STORM Therapeutics Presented Novel Pre-Clinical Data on STC-15 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics STORM Therapeutics Ltd
17-Oct-2023 Leading Proxy Advisor, ISS, Recommends Shareholders Vote “FOR” Danaher Corporation’s Proposed Acquisition of Abcam Abcam plc
17-Oct-2023 PATIENTS DOSED WITH METHYLONE IN LONDON IN NEW CLINICAL TRIAL TO TREAT PTSD Clerkenwell Health
17-Oct-2023 Cherwell to participate in sterile product manufacturing think tank discussions Cherwell
17-Oct-2023 Bloomsbury Genetic Therapies Receives Orphan Drug Designations from the European Commission and the US FDA for BGT-NPC for the Treatment of Niemann-Pick Disease Type C and Provides Update on Type B Pre-IND Interaction with the US FDA Bloomsbury Genetic Therapies Limited
17-Oct-2023 AI startup Leucine nets $7M to level up Pharma manufacturing compliance to keep pace with drug innovation Leucine nets $7M to level up pharma manufacturing compliance to keep pace with drug innovation
17-Oct-2023 Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma Cancer Treatment Tilray Medical
17-Oct-2023 Anaveon announces poster presentation at the 2023 European Society for Medical Oncology Annual Meeting Anaveon
17-Oct-2023 Myricx Bio to Present Preclinical Data Validating NMTi as a Novel ADC Payload Class Myricx Bio
17-Oct-2023 CD BioSciences Launches New 3D Tissue Imaging Services CD BioSciences
17-Oct-2023 HighRun DataScience Launches Data Science Platform for Global Customers HighRun DataScience
17-Oct-2023 CD BioSciences Launches New Services to Study Catabolism in Diabetes CD BioSciences
17-Oct-2023 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA ImmunOs Therapeutics
16-Oct-2023 Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive Disorder Teva Pharmaceuticals
13-Oct-2023 Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa UCB